Get the Stockscreener App
0.4485
0.95%
-0.0043
After Hours:
.42
-0.0285
-6.35%
Adial Pharmaceuticals Inc Stock (ADIL) Forecast
The Adial Pharmaceuticals Inc (ADIL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $20.97, representing a +4,575% increase from the current price of $0.4485. The highest analyst price target is $33.46, and the lowest is $8.4714.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ADIL Price Target
Average 29.15
(+6,398% Upside)
Is Adial Pharmaceuticals Inc (ADIL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 25.89 | Buy |
| STOCH(9,6) | 24.98 | Neutral |
| STOCHRSI(14) | 21.45 | Neutral |
| MACD(12,26) | -0.0445 | Sell |
| ADX(14) | 37.60 | Sell |
| William %R | -80.53 | Buy |
| CCI(14) | -219.06 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6007
Sell
|
0.5726
Sell
|
| MA20 |
0.6455
Sell
|
0.6162
Sell
|
| MA50 |
0.671
Sell
|
0.6667
Sell
|
| MA100 |
0.7236
Sell
|
0.7384
Sell
|
| MA200 |
0.8811
Sell
|
0.8875
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ADIL could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on ADIL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 25.89 indicates that ADIL is oversold. This indicates that ADIL price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 24.98 indicates that ADIL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 21.45 indicates that ADIL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 37.6 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -219.06 indicates that ADIL is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ADIL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Adial Pharmaceuticals Inc financial reports and earnings history, Adial Pharmaceuticals Inc (ADIL) stock could reach $58.46 by 2030, $33.48 by 2040 and $81.67 by 2050. See the projected annual prices until 2050 of the Adial Pharmaceuticals Inc stock below:
- Adial Pharmaceuticals Inc (ADIL) is expected to reach an average price of $11.92 in 2035, with a high prediction of $13.37 and a low estimate of $12.03. This indicates an $2,558% rise from the last recorded price of $0.4485.
- Adial Pharmaceuticals Inc (ADIL) stock is projected to chart a bullish course in 2040, with an average price target of $31.80, representing an $6,991% surge from its current level. The forecast ranges from a conservative $32.72 to a sky-high $33.48.
- Our analysts predict Adial Pharmaceuticals Inc (ADIL) to jump 15,536% by 2045, soaring from $69.95 to an average price of $70.13, potentially reaching $69.09. While $69.95 is the low estimate, the potential upside is significant.
- Adial Pharmaceuticals Inc (ADIL) stock is expected to climb by 2050, reaching an average of $82.97, a $18,399% jump from its current level. However, a wide range of estimates exists, with high and low targets of $81.67 and $83.07, respectively, highlighting the market's uncertainty.
Adial Pharmaceuticals Inc Stock (ADIL) Year by Year Forecast
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2025
Adial Pharmaceuticals Inc Stock (ADIL) is expected to reach an average price of $29.15 in 2025, with a high prediction of $57.88 and a low estimate of $0.4123. This indicates an +6,398% rise from the last recorded price of $0.4485.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $8.5969 | $8.4714 | $33.46 | +1,817% |
| August, 2025 | $9.088 | $10.72 | $8.9674 | +1,926% |
| September, 2025 | $2.671 | $7.579 | $18.67 | +495.53% |
| October, 2025 | $10.38 | $5.3893 | $7.8201 | +2,214% |
| November, 2025 | $13.63 | $10.75 | $57.88 | +2,939% |
| December, 2025 | $2.3273 | $0.4123 | $18.07 | +418.90% |
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2026
The predicted value for Adial Pharmaceuticals Inc (ADIL) in 2026 is set at an average of $48.08. Estimates vary from a peak of $95.50 to a trough of $0.6465, indicating an +10,619% surge from the present price of $0.4485.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.3362 | $0.6465 | $10.21 | +1,759% |
| February, 2026 | $5.8452 | $5.5952 | $18.78 | +1,203% |
| March, 2026 | $9.1041 | $0.7246 | $14.85 | +1,930% |
| April, 2026 | $36.30 | $9.0438 | $44.54 | +7,994% |
| May, 2026 | $26.31 | $8.6822 | $44.49 | +5,767% |
| June, 2026 | $23.07 | $17.25 | $28.07 | +5,044% |
| July, 2026 | $23.27 | $12.27 | $25.58 | +5,088% |
| August, 2026 | $32.78 | $20.46 | $38.53 | +7,208% |
| September, 2026 | $35.73 | $22.60 | $60.16 | +7,866% |
| October, 2026 | $35.49 | $23.55 | $51.42 | +7,812% |
| November, 2026 | $70.24 | $33.68 | $80.81 | +15,562% |
| December, 2026 | $75.69 | $66.06 | $95.50 | +16,777% |
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Adial Pharmaceuticals Inc (ADIL) is $44.45, with a high forecast of $85.70 and a low forecast of $3.2016. This indicates an +9,811% increase from the last price of $0.4485.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $56.20 | $56.20 | $85.70 | +12,431% |
| February, 2027 | $45.71 | $43.33 | $65.14 | +10,092% |
| March, 2027 | $36.91 | $31.16 | $48.90 | +8,130% |
| April, 2027 | $37.42 | $31.73 | $47.60 | +8,243% |
| May, 2027 | $32.68 | $23.93 | $37.86 | +7,186% |
| June, 2027 | $20.63 | $17.88 | $38.37 | +4,499% |
| July, 2027 | $24.64 | $18.07 | $29.39 | +5,393% |
| August, 2027 | $16.14 | $14.02 | $31.39 | +3,500% |
| September, 2027 | $7.8432 | $4.2137 | $16.83 | +1,649% |
| October, 2027 | $9.3522 | $6.3522 | $16.41 | +1,985% |
| November, 2027 | $9.3611 | $3.2016 | $11.54 | +1,987% |
| December, 2027 | $7.0621 | $4.3644 | $29.99 | +1,475% |
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2028
In 2028, Adial Pharmaceuticals Inc (ADIL) is projected to reach an average price of $8.0437, with a high projection of $11.41 and a low estimate of $4.674. This indicates an +1,693% rise from the last price of $0.4485.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.9838 | $7.5005 | $7.1813 | +1,680% |
| February, 2028 | $11.17 | $9.0468 | $9.3223 | +2,391% |
| March, 2028 | $11.60 | $11.20 | $11.41 | +2,486% |
| April, 2028 | $11.21 | $11.65 | $10.90 | +2,400% |
| May, 2028 | $11.74 | $11.71 | $11.14 | +2,518% |
| June, 2028 | $8.0096 | $9.0071 | $10.81 | +1,686% |
| July, 2028 | $6.9982 | $6.4379 | $7.1299 | +1,460% |
| August, 2028 | $2.797 | $4.674 | $4.7734 | +523.63% |
| September, 2028 | $6.5405 | $5.615 | $4.793 | +1,358% |
| October, 2028 | $5.5316 | $5.7813 | $5.7758 | +1,133% |
| November, 2028 | $5.3829 | $5.1521 | $5.5727 | +1,100% |
| December, 2028 | $6.369 | $6.0182 | $5.324 | +1,320% |
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2029
The 2029 price forecast for Adial Pharmaceuticals Inc Stock (ADIL) is $19.85 on average, with a high prediction of $39.48 and a low estimate of $0.2175. This represents an +4,326% increase from the previous price of $0.4485.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6003 | $3.7778 | $5.5017 | +479.78% |
| February, 2029 | $6.4364 | $4.9356 | $6.1364 | +1,335% |
| March, 2029 | $6.1774 | $5.4669 | $5.5574 | +1,277% |
| April, 2029 | $5.5785 | $5.5884 | $5.9477 | +1,144% |
| May, 2029 | $5.2398 | $5.4997 | $5.5893 | +1,068% |
| June, 2029 | $4.7307 | $4.7608 | $5.0501 | +954.79% |
| July, 2029 | $4.0219 | $4.1519 | $4.2014 | +796.75% |
| August, 2029 | $3.7931 | $3.8132 | $3.783 | +745.74% |
| September, 2029 | $3.3493 | $3.364 | $3.5335 | +646.77% |
| October, 2029 | $1.5256 | $1.0948 | $1.1156 | +240.16% |
| November, 2029 | $0.5367 | $0.7667 | $1.4761 | +19.66% |
| December, 2029 | $55.73 | $0.2175 | $39.48 | +12,326% |
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2030
Adial Pharmaceuticals Inc Stock (ADIL) is expected to reach an average price of $54.98 in 2030, with a high forecast of $68.51 and a low forecast of $41.44. This signifies an +12,158% surge from the last price of $0.4485.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $63.08 | $60.10 | $58.46 | +13,965% |
| February, 2030 | $61.56 | $66.20 | $64.44 | +13,626% |
| March, 2030 | $65.18 | $63.69 | $61.80 | +14,433% |
| April, 2030 | $68.53 | $71.41 | $66.03 | +15,180% |
| May, 2030 | $68.63 | $68.88 | $68.51 | +15,202% |
| June, 2030 | $66.99 | $69.36 | $66.55 | +14,836% |
| July, 2030 | $67.02 | $66.06 | $64.95 | +14,844% |
| August, 2030 | $42.45 | $51.70 | $65.59 | +9,365% |
| September, 2030 | $42.93 | $41.44 | $40.07 | +9,472% |
| October, 2030 | $61.03 | $49.05 | $52.28 | +13,508% |
| November, 2030 | $65.07 | $65.39 | $60.27 | +14,407% |
| December, 2030 | $64.44 | $64.38 | $61.50 | +14,267% |
1.12%
2.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):